Mathias Sauer

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Plasma Biomarkers for Neocortical Tau Burden.

Plasma Biomarkers for Neocortical Tau Burden.

Journal: JAMA neurology

Published: August 10, 2026

Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke.

Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke.

Journal: European journal of clinical investigation

Published: January 27, 2026

Cerebrospinal fluid NPTX2/p-tau ratio as a biomarker for cognitive decline in neurodegenerative diseases.

Cerebrospinal fluid NPTX2/p-tau ratio as a biomarker for cognitive decline in neurodegenerative diseases.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: December 12, 2025

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease.

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease.

Journal: Nature communications

Published: May 12, 2025

Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome.

Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 23, 2024

Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'.

Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'.

Journal: Molecular neurodegeneration

Published: September 25, 2024

Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.

Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.

Journal: Acta neuropathologica

Published: September 07, 2023

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.

Journal: Fluids and barriers of the CNS

Published: March 07, 2023

Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.

Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.

Journal: Nature aging

Published: November 27, 2022

SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.

SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 27, 2022

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum.

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum.

Journal: Molecular neurodegeneration

Published: September 10, 2022

Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers.

Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers.

Journal: Clinical proteomics

Published: February 02, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026